CDH11
Summary: This gene encodes a type II classical cadherin from the cadherin superfamily, integral membrane proteins that mediate calcium-dependent cell-cell adhesion. Mature cadherin proteins are composed of a large N-terminal extracellular domain, a single membrane-spanning domain, and a small, highly conserved C-terminal cytoplasmic domain. Type II (atypical) cadherins are defined based on their lack of a HAV cell adhesion recognition sequence specific to type I cadherins. Expression of this particular cadherin in osteoblastic cell lines, and its upregulation during differentiation, suggests a specific function in bone development and maintenance. [provided by RefSeq, Jul 2008].
| Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
|---|---|---|---|---|---|
| cadherin 11 | MIM:600023 | Ensembl:ENSG00000140937 | HGNC:HGNC:1750 | PA26284 | 16q21 |
GO terms in CDH11
| Term Type | Evidence Type | GO Term ID | GO Des. |
|---|---|---|---|
| BP | IBA | GO:0000902 | cell morphogenesis |
| BP | TAS | GO:0001501 | skeletal system development |
| BP | NAS | GO:0001503 | ossification |
| BP | IBA | GO:0007043 | cell-cell junction assembly |
| BP | TAS | GO:0007155 | cell adhesion |
| BP | IBA | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules |
| BP | IEA | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules |
| BP | IBA | GO:0007275 | multicellular organism development |
| BP | IBA | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules |
| BP | IEA | GO:0021957 | corticospinal tract morphogenesis |
| BP | IBA | GO:0031175 | neuron projection development |
| BP | IBA | GO:0034332 | adherens junction organization |
| BP | TAS | GO:0034332 | adherens junction organization |
| BP | IBA | GO:0044331 | cell-cell adhesion mediated by cadherin |
| CC | IEA | GO:0005737 | cytoplasm |
| CC | IBA | GO:0005886 | plasma membrane |
| CC | TAS | GO:0005886 | plasma membrane |
| CC | IBA | GO:0005913 | cell-cell adherens junction |
| CC | IBA | GO:0009986 | cell surface |
| CC | IEA | GO:0016021 | integral component of membrane |
| CC | IBA | GO:0016342 | catenin complex |
| CC | HDA | GO:0070062 | extracellular exosome |
| MF | IBA | GO:0005509 | calcium ion binding |
| MF | IEA | GO:0005509 | calcium ion binding |
| MF | IBA | GO:0008092 | cytoskeletal protein binding |
| MF | IBA | GO:0042803 | protein homodimerization activity |
| MF | IBA | GO:0045296 | cadherin binding |
Gene expression in normal tissue: CDH11
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in CDH11
| Database | Pathway ID | Pathway Des. |
|---|---|---|
| reactome | R-HSA-1500931 | Cell-Cell communication |
| reactome | R-HSA-418990 | Adherens junctions interactions |
| reactome | R-HSA-421270 | Cell-cell junction organization |
| reactome | R-HSA-446728 | Cell junction organization |
Gene-Drug: Aster Plot
| Drug ID | Drug Name | Model Num. |
|---|---|---|
| iGMDRD512 | nutlin 3 | 3 |
| iGMDRD79 | Gemcitabine | 2 |
| iGMDRD144 | NSC95397 | 4 |
| iGMDRD424 | Tamatinib | 2 |
| iGMDRD116 | CD437 | 3 |
| iGMDRD150 | RITA | 3 |
| iGMDRD61 | Kinetin riboside | 3 |
| iGMDRD152 | 179324-69-7 | 4 |
| iGMDRD499 | PDMP | 2 |
| iGMDRD351 | GW843682X | 3 |
| iGMDRD446 | LY 2183240 | 3 |
| iGMDRD297 | Austocystin D | 2 |
| iGMDRD255 | SB225002 | 4 |
| iGMDRD251 | ML162 | 2 |
| iGMDRD137 | Indisulam | 4 |
| iGMDRD138 | PX 12 | 1 |
| iGMDRD121 | GMX1778 | 2 |
| iGMDRD103 | SN-38 | 3 |
| iGMDRD289 | Parthenolide | 2 |
| iGMDRD577 | BIX01294 | 1 |
| iGMDRD399 | Selumetinib | 4 |
| iGMDRD414 | MST-312 | 6 |
| iGMDRD286 | Nsc 632839 | 5 |
| iGMDRD188 | Piperlongumine | 9 |
| iGMDRD322 | FK 866 | 1 |
| iGMDRD23 | Gossypol | 2 |
| iGMDRD263 | AACOCF3 | 1 |
| iGMDRD369 | TGX-115 | 3 |
| iGMDRD505 | Pevonedistat | 2 |
| iGMDRD886 | Compound 1541A | 2 |
| iGMDRD300 | Tozasertib | 2 |
Gene in drug-gene network: Network Plot

Gene-drug targets distribution
Gene Structure: PDB
Models in CDH11

